机译:The correlations between steady-state concentration, duration of action and molecular weight of GLP-1RAs and their efficacy and gastrointestinal side effects in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
Dept Endocrinol & Metab,Peking Univ Peoples Hosp;
glucagon-like peptide-1 receptor; type 2 diabetes; glycemic control; gastrointestinal side effect; GLUCAGON-LIKE PEPTIDE-1; RECEPTOR AGONISTS; OPEN-LABEL; PHARMACOKINETICS; EXENATIDE; LIRAGLUTIDE; SAFETY; PHARMACODYNAMICS; TOLERABILITY; TASPOGLUTIDE;